Avidity Biosciences
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $3,847 | $1,573 | $2,973 | $2,336 |
Gross Profit | 3,033 | 1,573 | 2,973 | 2,336 |
EBITDA | -171,142 | -130,732 | -120,252 | -97,424 |
EBIT | -171,956 | -131,517 | -120,990 | -98,134 |
Net Income | -157,315 | -115,773 | -102,257 | -80,398 |
Net Change In Cash | 3,847 | 1,573 | 2,973 | 2,336 |
Free Cash Flow | -203,009 | -128,582 | -103,787 | -67,319 |
Cash | 243,907 | 254,203 | 219,868 | 370,187 |
Basic Shares | 129,622 | 129,232 | 128,497 | 123,375 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $10,897 | $9,560 | $9,224 | $9,326 |
Gross Profit | 10,897 | 7,459 | 9,224 | 9,326 |
EBITDA | -376,160 | -233,497 | -177,526 | -117,412 |
EBIT | -378,936 | -235,598 | -178,913 | -118,051 |
Net Income | -322,302 | -212,220 | -169,077 | -117,370 |
Net Change In Cash | 10,897 | 9,560 | 9,224 | 9,326 |
Free Cash Flow | -307,936 | -123,292 | -139,091 | -98,553 |
Cash | 219,868 | 185,082 | 340,396 | 320,448 |
Basic Shares | 111,582 | 73,012 | 52,162 | 41,428 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$1.21 |
2025-03-31 | -$0.90 |
2024-12-31 | -$0.80 |
